COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026
25/06/2026
— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control — — Fanregratinib holds promise as a new treatment option for pretreated advanced [...]
FitRx Introduces Streamlined Tirzepatide Evaluation and Care Program
25/06/2026
New virtual-care process coordinates medical review, prescription support, insurance navigation and ongoing follow-up for eligible weight-management patients New York, NY, June 24, 2026 (GLOBE NEWSWIRE) -- FitRx [...]
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility
25/06/2026
Optimized capital structure, retiring short-term maturing debt Well-funded for commercial operations and growth pipeline NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global [...]
TWL Introduces Virtual Tirzepatide Assessment Program for Eligible Weight-Management Patients
25/06/2026
New digital-care process connects clinical evaluation, coverage assistance, pharmacy coordination and continuing provider support New York, NY, June 24, 2026 (GLOBE NEWSWIRE) -- TWL today announced the introduction of a [...]
Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
25/06/2026
REDWOOD CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that four oral [...]
Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors
24/06/2026
Bruce Booth, DPhil, Co-Founder and Chairman, to remain an Independent Director WATERTOWN, Mass., June 24, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company [...]
ARS Pharmaceuticals Provides Commercial and Financial Updates
24/06/2026
No new commercial formulary additions or coverage decisions issued for neffy ® (epinephrine nasal spray) in the July 1, 2026 cycle; company to continue payer discussions for potential future inclusion Total 2026 cash- [...]
Passage Bio and Remix Therapeutics Announce Merger Agreement
24/06/2026
Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin Remix’s lead program, REM [...]
Jushi Holdings Inc. Announces Voting Results of Annual General and Special Shareholders’ Meeting
24/06/2026
BOCA RATON, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announces the voting results of [...]
Prometheuz Introduces Online Testosterone Replacement Therapy Platform for U.S. Men Experiencing Low Testosterone
24/06/2026
New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Prometheuz announced the launch of its online testosterone replacement therapy (TRT) platform designed to connect men across the United States with licensed clinicians [...]
Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin
24/06/2026
CHICAGO, June 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today provided an update on the growing [...]
Modern Therapy Group launches virtual intensive outpatient program for mental health
25/06/2026
Structured, clinician-led care for clients who need more than weekly therapy New York, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Modern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults [...]
Breckenridge Distillery Rum Cask Finish Awarded Highest Honor at San Francisco World Spirits Competition
24/06/2026
Honey Whiskey Also Earns Gold, Reinforcing Breckenridge Distillery’s Global Recognition BRECKENRIDGE, Colo., June 24, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U [...]
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
24/06/2026
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
24/06/2026
FOSTER CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to [...]
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
24/06/2026
TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biopharmaceutical company developing exosome-based [...]
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
24/06/2026
"Mastery & Wellness: How to Thrive as a Physician" Offers 12 Physician CME Credits Iowa City, IOWA, June 24, 2026 (GLOBE NEWSWIRE) -- The Developing Doctor has unveiled its latest self-paced course, "Mastery & [...]
OSE Immunotherapeutics Reports Results of its 2026 Annual General Meeting
24/06/2026
NANTES, France, June 24, 2026 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company") , today reported that all 42 resolutions submitted to a vote at the Combined General Shareholders’ [...]
OSE Immunotherapeutics annonce les résultats de son Assemblée Générale Mixte 2026
24/06/2026
NANTES, France, le 24 juin 2026, 18h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société ») , annonce aujourd’hui que les 42 résolutions portées au vote de l’Assemblée Générale Mixte [...]

Pages